At its annual Investor Day in Paris today, SCOR presents its new three-year strategic plan, “Vision in Action” covering the period mid-2016 to mid-2019.
document
September 7, 2016 — 00:00
4334
-
-
Expert viewsAugust 30, 2016
Alexander Fleming’s discovery of Penicillin in 1928 marked one of the proudest achievements of 20th Century medicine. A decade of R&D later and suddenly mankind had the ability to fight a whole class of diseases.
-
Press ReleasesThe redemption of the two debts was already prefinanced.
-
The redemption of the two debts was already prefinanced
documentAugust 4, 2016 — 00:00 -
Press Releases
SCOR completed the calls of the entire balance of its EUR 350 million and CHF 650 million undated subordinated note lines on 28 July and 2 August 2016 respectively.
-
SCOR issued the EUR 350 million deeply subordinated notes on 28 July 2006. The amount outstanding was EUR 257 million.
documentAugust 3, 2016 — 00:00 -
-
-
Press Releases
Interim financial report for the first semester of 2016.
-
Press ReleasesHalf-year 2016 results.
-
The interim financial report for the six months ended 30 June 2016 is available on the company's website at www.scor.com.
documentJuly 27, 2016 — 00:00 -
SCOR records net income of EUR 275 million for the first six months of 2016, confirming the strength of its business model.
documentJuly 27, 2016 — 00:00
